地诺单抗去哪购买？

(Xgeva) is a fully humanized monoclonal antibody (IgG2 monoclonal antibody) that specifically targets receptor activator of nuclear factor-κB ligand (RANKL). It prevents RANKL from binding to its receptor substances, inhibits osteoclast activation and development, reduces bone resorption, and increases bone density. On May 28, 2010, the European Commission approved denosumab (Xgeva) for the treatment of bone loss associated with hormone suppression in postmenopausal women with osteoporosis and prostate cancer. It can also be used in patients who are currently ineffective or intolerant to other treatments to reduce the risk of fractures. Denosumab (Xgeva) was approved for the first time in 27 EU member states, as well as Norway, Iceland, and Liechtenstein. In June of the same year, this product was approved by the FDA for marketing.

Where should patients buy denosumab (Xgeva)?

Although this drug is already on the market in my country, it has not yet been officially sold in hospitals. Therefore, patients cannot buy this drug domestically. They can only buy it in other countries and regions where denosumab (Xgeva) is on the market. It is worth mentioning that the price of Amgen’s original drug denosumab (Xgeva) in Turkey is the lowest in the world. The specification of denosumab in Turkey is 125mg/1ml tube/box, and the price is equivalent to RMB 3,000.

If domestic patients want to purchase Turkish denosumab (Xgeva), they should choose formal drug purchase channels. There are currently many counterfeit drugs in Turkey on the market. The use of counterfeit drugs for treatment not only poses a major hidden danger to the patient's life safety, but also has a low effective concentration of the drug in the counterfeit drugs, which may develop drug resistance and make it difficult to treat the disease even if it is taken with genuine drugs. Therefore, it is recommended that patients get their medicines directly from regular Turkish hospitals. In addition, you can also obtain genuine products listed in Türkiye through domestic professional overseas medical service institutions.